338 related articles for article (PubMed ID: 19852753)
1. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
2. Juvenile idiopathic arthritis - an update on pharmacotherapy.
Kahn P
Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
[TBL] [Abstract][Full Text] [Related]
3. Juvenile idiopathic arthritis: an update for the clinician.
Kahn P
Bull NYU Hosp Jt Dis; 2012; 70(3):152-66. PubMed ID: 23259622
[TBL] [Abstract][Full Text] [Related]
4. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
[TBL] [Abstract][Full Text] [Related]
5. Update on treatment of arthritis in children: new treatments, new goals.
Lovell DJ
Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
[TBL] [Abstract][Full Text] [Related]
6. New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):151-6. PubMed ID: 19770495
[TBL] [Abstract][Full Text] [Related]
7. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
[TBL] [Abstract][Full Text] [Related]
8. Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations.
Barr T; Carmichael NM; Sándor GK
J Can Dent Assoc; 2008 Nov; 74(9):813-21. PubMed ID: 19000466
[TBL] [Abstract][Full Text] [Related]
9. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis.
Riddle R; Ryser CN; Morton AA; Sampson JD; Browne RH; Punaro MG; Gatchel RJ
J Pediatr Psychol; 2006 Apr; 31(3):262-71. PubMed ID: 15872147
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA).
Verma S; Gupta R; Lodha R; Kabra SK
Indian Pediatr; 2009 Mar; 46(3):264-5. PubMed ID: 19346579
[TBL] [Abstract][Full Text] [Related]
11. Current management of juvenile idiopathic arthritis.
Wallace CA
Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):279-300. PubMed ID: 16546057
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
[TBL] [Abstract][Full Text] [Related]
14. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
Kump LI; Castañeda RA; Androudi SN; Reed GF; Foster CS
Ophthalmology; 2006 Oct; 113(10):1874-7. PubMed ID: 16884776
[TBL] [Abstract][Full Text] [Related]
15. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?
Butbul YA; Tyrrell PN; Schneider R; Dhillon S; Feldman BM; Laxer RM; Saurenmann RK; Spiegel L; Cameron B; Tse SM; Silverman ED
J Rheumatol; 2009 Sep; 36(9):2033-41. PubMed ID: 19648305
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
Foeldvari I; Wierk A
J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
[TBL] [Abstract][Full Text] [Related]
17. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
[TBL] [Abstract][Full Text] [Related]
18. Advanced therapy for juvenile arthritis.
Murray KJ; Lovell DJ
Best Pract Res Clin Rheumatol; 2002 Jul; 16(3):361-78. PubMed ID: 12387805
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease.
Grassi A; Corona F; Casellato A; Carnelli V; Bardare M
J Rheumatol; 2007 May; 34(5):1139-45. PubMed ID: 17343317
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
